Fractal Analytics Posts Rs 100 Cr PAT in Q3, Driven by Healthcare and AI Product Wins
Event summary
- Fractal Analytics reported Rs 854.4 Cr revenue in Q3 FY26, up 21% YoY, with Healthcare (20% of revenue) growing 78% YoY and BFSI (12%) up 26% YoY.
- Adjusted EBITDA rose 24% YoY to Rs 152.1 Cr, with margins expanding 0.4% YoY to 17.8%, while PAT crossed Rs 100 Cr.
- Net Revenue Retention stood at 114%, with NPS at 77; clients generating >$20M revenue increased by 2 YoY to 6.
- Vaidya.ai 2.0 achieved a 50+ score on OpenAI's HealthBench (Hard), outperforming ChatGPT-5, GPT-5.2, and Gemini Pro 3.
- PiEvolve ranked among top agents on OpenAI's MLE-Bench, surpassing Google, Microsoft, and Meta.
The big picture
Fractal's strong Q3 performance underscores the accelerating AI adoption in enterprise sectors like healthcare and financial services. The company's ability to outperform global benchmarks with products like Vaidya.ai and PiEvolve positions it as a key player in the AI-driven decision-making space. With a disciplined focus on high-margin, client-centric AI solutions, Fractal is well-positioned to capitalize on the growing demand for autonomous machine learning and scientific discovery tools.
What we're watching
- AI Product Leadership
- Whether Fractal can sustain its AI product dominance amid competition from Google, Microsoft, and Meta.
- Client Concentration
- The pace at which Fractal expands its $20M+ revenue clients to reduce reliance on top-tier accounts.
- Healthcare Growth
- How Fractal scales its 78% YoY healthcare segment growth amid regulatory and competitive pressures.
Related topics